Font Size:
a
A
A
Keyword [Chronic Myelogenous Leukemia]
Result: 121 - 140 | Page: 7 of 10
121.
MiR-224-3p Regulates The Multidrug Resistance Of Chronic Myelogenous Leukemia By Targeting FUT4
122.
Efficacy Of 2nd Generation’s TKI In Treatment Of Imatinib Resistant Or Intolerant Chronic Myelogenous Leukemia
123.
Investigation The Mechanisms Of Drug Resistance In Chronic Myeloid Leukemia Cell Line-K562/ADR
124.
The Role Of PPFIA1 And The Identification Of The Phosphorylation Signaling Molecules And Interactive Proteins In Chronic Myelogenous Leukemia(CML) Cells
125.
Research On The Epigenetic Regulation Mechanism Of The PTPN6 Gene In Advanced Chronic Myeloid Leukemia
126.
Sensing Nucleic Acids Based On DNA Nanotechnology And Catalytic Nucleic Acids With Chemiluminescence
127.
In Vitro And In Vivo Study Of Nickel Pyrithione Overcome Imatinib Resistance In Chronic Myeloid Leukemia
128.
The Therapeutic Effect Analysis Of Tyrosine Kinase Inhibitor And Chemotherapy Combined Treatment To Chronic Myelogenous Leukemia In Blastic Phase Patients
129.
Study On Usage Status Of Medical Insurance Special Drugs In Jiangsu Province
130.
Design And Synthesis Of Bcr-Abl Tyrosine Kinase Inhibitors
131.
The Expression And Significance Of BATF, CST1, PLD1 And PTHLH Gene In The Patients Of Chronic Myelogenous Leukemia
132.
The Bioinformatics And Clinical Epidemilogy Analysis Of Related Genes In The Progression Of CML To AML
133.
Analysis Of The Emergence Of ABL Kinase Domain Mutations In Chronic Myelogenous Leukemia Treated With Tyrosine Kinase Inhibitor
134.
The Clinical Research Of Imatinib Mesylate In Children Chronic Myelogenous Leukemia
135.
The Curative Effect Analysis Of Imatinib On 58 Cases Of Chronic Myelogenous Leukemia In Chronic Phase
136.
Effect Of Homoharringtonine On Proliferation And Apoptosis On Imatinib-resistant Chronic Myelogenous Leukemia Cells And The Relationship With Bcl-6/p53 Pathway
137.
The Role And Mechanism Of SOX4 Gene In Chronic Myelogenous Leukemia
138.
The Mechanism Of STAT5-ROS Pathway Involved In Resistance To Imatinib In Chronic Myeloid Leukemia
139.
Clinical Preliminary Observation Of Domestic Imatinib And Glivec Treatment Of Chronic Myelogenous Leukemia In Chronic Phase And Literature Review
140.
Clinical And Molecular Genetic Study On Chronic Myeloid Leukemia Thrated By Second Generation Tyrosine Kinase Inhibitors
<<First
<Prev
Next>
Last>>
Jump to
